Exciting times ahead in the Chinese mainland’s healthcare sector! 🎉 Steven Lynum, president of the U.S.-based precision diagnostics company Epredia, revealed that the market is expected to grow by roughly 7% in 2024. 📈 Lynum emphasized that offering more products manufactured in the Chinese mainland to support local needs is a \"huge opportunity.\" 🚀 With the region's unique healthcare landscape, Epredia is set to make a significant impact!
